Privi Speciality Chemicals Ltd logo

Privi Speciality Chemicals Ltd

PRIVISCL NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹13,541 Cr
Volatility
Moderate
P/E Ratio
38.61
EBITDA
₹666 Cr
Return on Equity
21.99%
Debt to Equity
0.72
Book Value
₹361.58
EPS
₹31.14
52W High
₹3,785.3
52W Low
₹2,193.9

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Privi Speciality Chemicals Ltd insights

45 extracted metrics + investor summaries across FY12–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

1
  • Company has delivered good profit growth of 26.8% CAGR over last 5 years

Weaknesses

2
  • Stock is trading at 9.55 times its book value
  • Promoter holding has decreased over last 3 years: -13.4%

Growth Rate

Revenue Growth
21.73% ↗
Net Income Growth
71.37% ↗
Cash Flow Change
95.68% ↗
ROE
33.03% ↗
ROCE
23.69% ↗
EBITDA Margin (Avg.)
15.26% ↗

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk high

Privi Speciality Chemicals trades at a market cap of Rs 13,782 crore with a PE of 40.9x and PB of 9.9x. The company has delivered strong profit growth of 61% TTM and 144% CAGR over 3 years, while the stock has appreciated 48% over the last year. Promoter holding has declined by 13.4% over three years, and valuations remain elevated relative to book value.

Bull Case 8
  • TTM profit growth of 61% indicates strong earnings momentum and operational leverage
  • 3-year compounded profit CAGR of 144% reflects a dramatic earnings turnaround
  • Last year ROE of 26% is well above the 5-year average of 15%, showing improving capital efficiency
  • 5-year compounded profit CAGR of 27% demonstrates sustained long-term earnings delivery
  • TTM sales growth of 22% suggests healthy topline expansion and demand visibility
  • Stock CAGR of 28% over 10 years indicates consistent long-term wealth creation
  • 5-year compounded sales CAGR of 15% shows steady revenue scaling in the specialty chemicals space
  • 3-year ROE average of 19% comfortably exceeds cost of equity for most chemical companies
Bear Case 8
  • Stock trades at 9.91x book value, which is expensive relative to specialty chemical peers
  • PE of 40.9x leaves little room for execution missteps or margin compression
  • Promoter holding has decreased by 13.4% over 3 years, signaling potential dilution or reduced promoter confidence
  • Dividend yield of just 0.28% offers minimal income cushion in a downturn
  • 3-year stock CAGR of 52% far outpaces 3-year sales CAGR of 17%, suggesting valuation has run ahead of fundamentals
  • 10-year compounded sales and profit growth data is incomplete, limiting long-cycle visibility
  • 1-year stock CAGR of 48% versus TTM sales growth of 22% implies market is pricing in forward growth that may not materialize
  • Debt-to-equity ratio is unavailable, making it difficult to assess balance sheet leverage and financial risk

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2d ago
Positives 2
  • Strong Q1 profit growth Jul 30

    Standalone net profit rose 22.7% YoY to ₹84.26 crore in Q1FY26; consolidated net profit surged 43.9% YoY to ₹82.84 crore, driven by higher revenue.

  • ₹10 final dividend declared Aug 7

    Board declared a final dividend of ₹10 per share for FY26 at the 41st AGM held on August 7, 2026, signaling confidence in cash flows.

Neutral 2
  • Investor meet scheduled Aug 18 Aug 11

    Privi scheduled an analyst and institutional investor meeting for August 18, 2026, in Mumbai, organized by MOSL, covering publicly available information.

  • Q1 FY27 earnings call planned Jul 23

    Management will host an earnings call on July 31, 2026, to discuss Q1 FY27 operational and financial results.

TL;DR: Privi Speciality Chemicals is delivering solid earnings momentum with over 22% standalone and 43% consolidated profit growth in Q1, supported by a healthy ₹10 dividend. No material headwinds are visible in recent news flow. The upcoming investor meet and earnings call should provide further clarity on whether this growth trajectory is sustainable into FY27.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
409
455
404
484
464
533
491
614
559
679
605
722
666
Expenses
354
366
314
393
370
423
378
481
427
497
453
541
514
Operating Profit
55
89
90
91
94
110
113
133
132
182
151
180
152
OPM %
13%
20%
22%
19%
20%
21%
23%
22%
24%
27%
25%
25%
23%
Other Income
6
7
6
8
3
4
2
15
9
0
7
4
15
Interest
24
25
24
25
22
22
22
23
24
21
19
18
17
Depreciation
31
31
32
30
32
32
32
35
36
36
36
36
37
PBT
6
40
39
44
43
61
61
90
81
125
104
130
113
Tax %
30%
25%
26%
28%
27%
26%
27%
29%
29%
28%
28%
27%
27%
Net Profit
5
30
29
32
31
45
44
64
58
90
75
94
83
EPS in Rs
1.18
7.8
7.36
7.93
8.02
11.42
11.37
17.01
15.84
24.02
19.95
23.96
21.54
Figures in ₹ Crores

Profit & Loss

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
597
1,024
1,341
1,631
1,277
1,404
1,608
1,752
2,101
2,564
2,671
Expenses
525
894
1,128
1,362
1,067
1,209
1,420
1,423
1,643
1,912
2,005
Operating Profit
72
130
213
268
210
195
188
329
458
651
666
OPM %
12%
13%
16%
16%
16%
14%
12%
19%
22%
25%
25%
Other Income
10
16
14
66
43
38
21
26
20
19
26
Interest
20
24
29
41
24
25
70
102
92
87
75
Depreciation
27
43
47
63
71
75
108
123
132
144
145
PBT
36
79
152
231
158
133
31
130
255
440
472
Tax %
24%
32%
38%
24%
26%
27%
31%
27%
27%
28%
—
Net Profit
27
53
94
176
117
97
21
95
185
317
342
EPS in Rs
7.21
14.19
24.1
45.1
29.9
24.91
5.68
24.27
47.83
83.77
89.47
Div. Payout %
14%
11%
10%
3%
7%
8%
0%
8%
10%
12%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
38
38
39
39
39
39
39
39
39
39
Reserves
406
451
537
702
683
773
790
885
1,064
1,373
Borrowings
321
330
491
569
537
933
1,079
1,008
1,143
1,021
Other Liabilities
174
235
359
294
281
431
483
410
544
736
Total Liabilities
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170
Fixed Assets
388
437
498
725
598
704
1,017
1,034
1,156
1,169
CWIP
24
49
95
40
175
373
100
99
141
314
Investments
1
3
0
1
0
12
7
40
8
54
Other Assets
527
564
833
839
768
1,087
1,268
1,169
1,485
1,633
Total Assets
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170
Figures in ₹ Crores

Cash Flow

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
17
107
21
247
172
5
49
354
281
550
Investing
80
-81
-139
-206
-242
-321
-133
-180
-294
-358
Financing
-89
-20
122
27
0
333
72
-171
39
-198
Net Cash Flow
7
5
4
68
-69
17
-12
4
26
-6
Free Cash Flow
17
107
46
37
-71
-304
-91
212
-17
230
CFO/OP
49
96
24
120
101
19
33
116
77
102
Figures in ₹ Crores

Ratios

  Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
106
82
90
60
68
69
67
72
68
75
Inventory Days
236
132
162
135
170
279
311
245
262
235
Days Payable
115
85
95
55
83
138
114
105
134
150
Cash Conversion Cycle
227
129
157
139
155
209
264
212
197
160
Working Capital Days
31
20
40
45
65
19
16
37
35
54
ROCE %
—
13%
18%
20%
12%
10%
6%
12%
16%
22%

Shareholding Pattern

As of Jun 2026
Promoters 60.60%
Public 17.74%
DIIs 10.08%
Others 9.64%
FIIs 1.94%
Total 100.00%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
74.06%
74.06%
74.06%
74.06%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
74.05%
69.89%
69.89%
60.60%
60.60%
60.60%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.97%
0.96%
0.62%
0.48%
0.43%
0.48%
0.40%
1.47%
1.33%
1.64%
1.38%
1.94%
DIIs
1.81%
1.68%
2.39%
2.92%
3.14%
3.08%
3.09%
3.60%
3.74%
3.26%
3.37%
3.40%
3.37%
2.84%
2.50%
2.09%
1.95%
3.90%
4.55%
10.24%
10.67%
10.08%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
12.84%
12.83%
12.46%
12.01%
11.53%
11.59%
11.61%
11.54%
10.99%
10.93%
10.85%
10.83%
11.03%
13.54%
13.73%
14.11%
14.16%
15.56%
15.38%
15.41%
18.17%
17.74%
Others
11.29%
11.43%
11.10%
11.02%
11.28%
11.28%
11.25%
10.82%
11.22%
11.76%
10.75%
10.77%
10.92%
9.09%
9.30%
9.27%
9.44%
9.18%
8.85%
12.11%
9.18%
9.64%
No. of Shareholders
11,454
17,435
25,894
24,856
25,381
21,771
21,187
20,601
19,977
19,437
18,224
17,702
16,821
17,029
16,372
18,131
16,721
28,685
28,203
32,016
34,415
44,875

Documents

Frequently Asked Questions about Privi Speciality Chemicals Ltd

What does Privi Speciality Chemicals Ltd do?
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]
Where is Privi Speciality Chemicals Ltd (PRIVISCL) listed?
Privi Speciality Chemicals Ltd is listed on the Indian stock exchanges. It is listed on NSE: PRIVISCL and BSE: 530117. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Privi Speciality Chemicals Ltd belong to?
Privi Speciality Chemicals Ltd operates in the Chemicals sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd has a market capitalisation of approximately ₹13540.70 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Privi Speciality Chemicals Ltd?
The Price-to-Earnings (PE) ratio of Privi Speciality Chemicals Ltd is 38.61. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Privi Speciality Chemicals Ltd?
Over the past 52 weeks, Privi Speciality Chemicals Ltd has traded between a low of ₹2,193.9 and a high of ₹3,785.3. This range helps investors understand the stock's price volatility and recent trading levels.
Does Privi Speciality Chemicals Ltd pay dividends?
Yes, Privi Speciality Chemicals Ltd has a dividend yield of 0.29%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd has a Return on Equity (ROE) of 21.99%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Privi Speciality Chemicals Ltd on Tapetide?
On Tapetide, you can view Privi Speciality Chemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]

Website privi.com
CEO Mr. Mahesh Purshottambhai Babani
Employees 672
Listed 2015-05-08
Face Value ₹ 10
Issued Size 3,90,62,706

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List